TY - JOUR
T1 - Projecting complete redaction of clinical trial protocols (RAPTURE)
T2 - Redacted cross sectional study
AU - Balaban, Nir
AU - Mohyuddin, Ghulam Rehman
AU - Kashi, Adi
AU - Massarweh, Amir
AU - Markel, Gal
AU - Bomze, David
AU - Goldstein, Daniel A.
AU - Meirson, Tomer
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2019.
PY - 2023/12/14
Y1 - 2023/12/14
N2 - Objectives: To characterise redactions in clinical trials and estimate a time when all protocols are fully removed (RAPTURE). Design: Redacted cross sectional study. Setting: Published phase 3 randomised controlled trials from 1 January 2010 to . Participants: New England Journal of Medicine, , and Journal of the American Medical Association. Main outcome measures: met the inclusion criteria, with 268 (56.7%) research protocols available and accessible. The rate of redactions in protocols has increased from 0 in 2010 to 60.8% in 2021 (P<0.001). The degree of data redaction has also increased, with the average cumulative redactions among industry funded trials rising from 0 in 2010 to 3.5 pages in 2021 (P<0.001). Modelling predicts that RAPTURE is expected to occur between 2073 and 2136. Redactions featured predominantly in sponsored trials and mostly occurred in the statistical design. Conclusions: This study highlights the rise in protocol redactions and predicts that, will be entirely redacted between 2073 and 2136. A legitimate rationale for the redactions could be found. A multipronged strategy against protocol redactions is required to maintain the integrity of science. Availability: This paper is partially redacted, but for the sake of a version without any redactions can be found in the supplementary material.
AB - Objectives: To characterise redactions in clinical trials and estimate a time when all protocols are fully removed (RAPTURE). Design: Redacted cross sectional study. Setting: Published phase 3 randomised controlled trials from 1 January 2010 to . Participants: New England Journal of Medicine, , and Journal of the American Medical Association. Main outcome measures: met the inclusion criteria, with 268 (56.7%) research protocols available and accessible. The rate of redactions in protocols has increased from 0 in 2010 to 60.8% in 2021 (P<0.001). The degree of data redaction has also increased, with the average cumulative redactions among industry funded trials rising from 0 in 2010 to 3.5 pages in 2021 (P<0.001). Modelling predicts that RAPTURE is expected to occur between 2073 and 2136. Redactions featured predominantly in sponsored trials and mostly occurred in the statistical design. Conclusions: This study highlights the rise in protocol redactions and predicts that, will be entirely redacted between 2073 and 2136. A legitimate rationale for the redactions could be found. A multipronged strategy against protocol redactions is required to maintain the integrity of science. Availability: This paper is partially redacted, but for the sake of a version without any redactions can be found in the supplementary material.
UR - http://www.scopus.com/inward/record.url?scp=85179770671&partnerID=8YFLogxK
U2 - 10.1136/bmj-2023-077329
DO - 10.1136/bmj-2023-077329
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38097263
AN - SCOPUS:85179770671
SN - 0959-8146
JO - BMJ
JF - BMJ
M1 - 077329
ER -